NEUBASE THERAPEUTICS INC
COM · CUSIP 64132K102
3
institutional holders
-34 vs Q1 2023
97.2k
shares reported held*
$180.8kreported value*
1 new
0 added
2 reduced
35 sold out
net sold ≈ $17.2m (-9.2m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.86.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 45 |
| Q4 2022 | 36 |
| Q1 2023 | 37 |
| Q2 2023 | 3 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 9 | 22 |
| Q1 2023 | 9 | 10 |
| Q2 2023 | 1 | 37 |
Biggest buyers
| IFP Advisors, Inc | New | +200 |
Biggest sellers
| GREENLIGHT CAPITAL INC | Sold out | -2.7m |
| Point72 Asset Management, L.P. | Sold out | -1.2m |
| Decheng Capital Management III (Cayman), LLC | Reduced | -950.0k |
| Carnegie Mellon University | Reduced | -892.4k |
| Polar Asset Management Partners Inc. | Sold out | -634.6k |
| Kestra Advisory Services, LLC | Sold out | -509.7k |
| VANGUARD GROUP INC | Sold out | -376.8k |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | Sold out | -313.1k |
| PRELUDE CAPITAL MANAGEMENT, LLC | Sold out | -311.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -234.0k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Decheng Capital Management III (Cayman), LLC 0.03% of their portfolio | 50.0k $92.5k | Reduced -950.0k |
| Carnegie Mellon University 0.12% of their portfolio | 47.0k $87.8k | Reduced -892.4k |
| IFP Advisors, Inc 0.00% of their portfolio | 200 $470 | New |